18. Monthly Frequency 18. Source Acute Non Foundation Trust (75) , Acute Foundation Organisations Trust (96) (Number of orgs) 19. Set Up Costs 20. Other Costs 21. Total £ 62282.3 Costs 22. Please The collection, the collection has been designed so that explain the it can also fulfil the current requirement for the annual reason for aggregate KH12 collection. The KH12 aggregate return any increase is scheduled to imminently due to the or decrease implementation of the dataset. The dataset itself has in burden and now been collected since 2012 and will continue in its provide current form, and so there is no change in burden for details of the those providing this data, aside from the removal of the any other KH12. There are no set up costs as there are no costs figure changes as a result of this application. Regarding KH12, provided in a report of the consultation was published on the Q20 consultation website. Further notifications of its discontinuation were put on Unify and on the NHS England statistical publication pages and various individuals were informed by email. There has been no cost associated with any of this. 23. Benefits Key to the Coalition Government's ambition to close the to Patients gap in cancer survival rates between England and Europe, set out in the Department of Health’s Improving and the NHS Outcomes: A Strategy for Cancer (IOSC), is achieving earlier diagnosis of cancer. The National Awareness and Earlier Diagnosis Initiative (NAEDI) has evidence linking late diagnosis with poor survival and avoidable deaths.
18. Frequency Monthly 18. Source Organisations (Number of orgs) Acute Non Foundation Trust (75) , Acute Foundation Trust (96) 19. Set Up Costs 20. Other Costs 21. Total Costs £ 62282.3 22. Please explain the reason for any increase or decrease in burden and provide details of the any other costs figure provided in Q20 The collection, the collection has been designed so that it can also fulfil the current requirement for the annual aggregate KH12 collection. The KH12 aggregate return is scheduled to imminently due to the implementation of the dataset. The dataset itself has now been collected since 2012 and will continue in its current form, and so there is no change in burden for those providing this data, aside from the removal of the KH12. There are no set up costs as there are no changes as a result of this application. Regarding KH12, a report of the consultation was published on the consultation website. Further notifications of its discontinuation were put on Unify and on the NHS England statistical publication pages and various individuals were informed by email. There has been no cost associated with any of this. 23. Benefits to Patients and the NHS Key to the Coalition Government's ambition to close the gap in cancer survival rates between England and Europe, set out in the Department of Health’s Improving Outcomes: A Strategy for Cancer (IOSC), is achieving earlier diagnosis of cancer. The National Awareness and Earlier Diagnosis Initiative (NAEDI) has evidence linking late diagnosis with poor survival and avoidable deaths.
R00291%20BAAS%20Application.docx